MiR-181a promotes cell proliferation and migration through targeting KLF15 in papillary thyroid cancer

被引:0
作者
C. X. Sun
B. J. Liu
Y. Su
G. W. Shi
Y. Wang
J. F. Chi
机构
[1] Yantaishan Hospital,Department of Endocrinology
[2] Rizhao Hospital of TCM,Operation Room
[3] Qingdao Hiser Hospital,Operation Room, Qingdao Hospital of Traditional Chinese Medicine
[4] Zhangqiu District People’s Hospital,Health Management Center
[5] Jinan Central Hospital,Department of Endocrinology
来源
Clinical and Translational Oncology | 2022年 / 24卷
关键词
miR-181a; KLF15; Proliferation; Migration; Papillary thyroid cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:66 / 75
页数:9
相关论文
共 124 条
[1]  
Cabanillas ME(2016)Thyroid cancer Lancet 388 2783-2795
[2]  
McFadden DG(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[3]  
Durante C(2008)Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma Minerva Endocrinol 33 359-379
[4]  
Siegel RL(2015)Thyroid cancer mortality and incidence: a global overview Int J Cancer 136 2187-2195
[5]  
Miller KD(2013)New developments in the diagnosis and treatment of thyroid cancer CA Cancer J Clin 63 374-394
[6]  
Jemal A(2009)MicroRNAs: target recognition and regulatory functions Cell 136 215-233
[7]  
Pelizzo MR(2004)MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 281-297
[8]  
Merante BI(2019)MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways J Cell Physiol 234 18382-18391
[9]  
Toniato A(2019)Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma Biomed Pharmacother 114 3355-3361
[10]  
La Vecchia C(2019)Serum miR-22 may be a biomarker for papillary thyroid cancer Oncol Lett 17 144-342